These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 12895200)
61. A case of irreversible leukoencephalopathy in a patient with C virus hepatitis treated with pegylated interferon-alpha-2b and ribavirin. Iacob SA; Petrescu AM; Iacob DG Rom J Intern Med; 2013; 51(3-4):197-200. PubMed ID: 24620633 [TBL] [Abstract][Full Text] [Related]
62. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Puoti M; Babudieri S; Rezza G; Viale P; Antonini MG; Maida I; Rossi S; Zanini B; Putzolu V; Fenu L; Baiguera C; Sassu S; Carosi G; Mura MS Antivir Ther; 2004 Aug; 9(4):627-30. PubMed ID: 15456094 [TBL] [Abstract][Full Text] [Related]
63. New interferon approved for chronic hepatitis C. Am J Health Syst Pharm; 1997 Dec; 54(23):2656. PubMed ID: 9408506 [No Abstract] [Full Text] [Related]
64. Adverse response to pegylated interferon therapy in two patients with chronic hepatitis C. Thomas WL; Ramos F; Hospenthal DR Hawaii Med J; 2003 Aug; 62(8):163-4. PubMed ID: 14533347 [TBL] [Abstract][Full Text] [Related]
65. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270 [TBL] [Abstract][Full Text] [Related]
66. Elevated hepatic transaminases associated with the use of interferon alfacon-1 and ribavirin. Kleppinger EL; Ragan AP Am J Health Syst Pharm; 2009 Mar; 66(5):465-8. PubMed ID: 19233994 [TBL] [Abstract][Full Text] [Related]
67. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases]. Vinagre I; Rigla M; Torras X; Enríquez J; Corcoy R Endocrinol Nutr; 2010 Oct; 57(8):393-5. PubMed ID: 20462813 [No Abstract] [Full Text] [Related]
68. [Convulsive seizure during a treatment with interferon alpha for chronic viral hepatitis C]. Verger P; De Monredon J; Blais J Gastroenterol Clin Biol; 1997; 21(11):902-3. PubMed ID: 9587549 [No Abstract] [Full Text] [Related]
69. Peginterferon and ribavirin for hepatitis C. Evoli A; Servidei S N Engl J Med; 2007 Mar; 356(12):1269-70; author reply 1271. PubMed ID: 17380575 [No Abstract] [Full Text] [Related]
70. Acute reversible rhabdomyolysis during interferon alpha2B therapy for hepatitis C. Gabrielli M; Santarelli L; Serricchio M; Leo D; Pola P; Gasbarrini A Am J Gastroenterol; 2003 Apr; 98(4):940. PubMed ID: 12738487 [No Abstract] [Full Text] [Related]
71. [Dysacusia associated with pegylated-interferon and ribavirin combination therapy during chronic hepatitis C treatment: a report of two cases]. Jia YH; Gao SJ; Nan YM Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):67-8. PubMed ID: 22489302 [No Abstract] [Full Text] [Related]
72. Treatment of ribavirin/interferon-induced anemia with erythropoietin in patients with hepatitis C. Gergely AE; Lafarge P; Fouchard-Hubert I; Lunel-Fabiani F Hepatology; 2002 May; 35(5):1281-2. PubMed ID: 11981781 [No Abstract] [Full Text] [Related]
73. Bilateral non-arteritic ischemic optic neuropathy associated with pegylated interferon for chronic hepatitis C. Chan JW Eye (Lond); 2007 Jun; 21(6):877-8. PubMed ID: 17318204 [No Abstract] [Full Text] [Related]
74. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha]. Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017 [No Abstract] [Full Text] [Related]